Cencora Inc (WBO:ABC)
€ 254.3 -0.70 (-0.27%) Market Cap: 49.00 Bil Enterprise Value: 58.15 Bil PE Ratio: 21.95 PB Ratio: 16.38 GF Score: 69/100

Cencora Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 05:00PM GMT
Release Date Price: €287.15 (-0.43%)
Lisa Gill
JPMorgan Chase & Co - Analyst

Good morning, and thank you for joining us. My name is Lisa Gill, and I head up Healthcare Services at JPMorgan. It is with great pleasure this morning that we have with us Cencora. Presenting for Cencora will be CEO, Bob Mauch. In addition, we have Jim Cleary, CFO, who will join me for the Q&A session.

With that, I'm going to turn it over to Bob.

Robert Mauch
Cencora Inc - President, Chief Executive Officer, Director

Thank you, Lisa. Hi, everyone. Thank you for being here. Thank you for your interest in Cencora. I'll pause here for our cautionary note regarding forward-looking statements. And if you would like additional information, please go to our website at investor.cencora.com.

So Cencora is a global pharmaceutical services health care company. We ship more than 1 billion medications yearly through our MSO investments. We have the number one retina research network, 51,000 purpose-driven team members. And in the past year, we were fortunate to increase our revenue by 9% year-over-year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot